Has Elizabeth Chambers received payments from drug or device companies?

Yes. Drug and device makers reported $3,017 in general payments to Elizabeth Chambers across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elizabeth Chambers did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elizabeth Chambers come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elizabeth Chambers

Child & Adolescent Psychiatry · Hood River, ORNPI 1598848475

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 24.9% of the total. Reporting peaked in 2021 at $616 and has fallen 60.9% since, to $241 in 2025. Among child & adolescent psychiatry clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,017in general payments, 2019–2025

Across 127 payments — averaging $23.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$752
AbbVie$538
Otsuka America Pharmaceutical, Inc.$298
Acadia Pharmaceuticals Inc$262
Johnson & Johnson$257
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$252
plus $659 from 11 others

What the payments were for

Food & beverage$2,78792%
Education$2308%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	17	$752
AbbVie(2 entities)	36	$538
Otsuka America Pharmaceutical, Inc.	11	$298
Acadia Pharmaceuticals Inc	12	$262
Johnson & Johnson	12	$257
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$252
Supernus Pharmaceuticals, Inc.	8	$197
E.r. Squibb & Sons, L.L.C.	1	$125
Alkermes, Inc.	5	$90
Ironshore Pharmaceuticals Inc.	4	$61
Vanda Pharmaceuticals Inc.	3	$45
Eisai Inc.	2	$36
Takeda Pharmaceuticals U.S.A., Inc.	2	$32
Biogen	1	$23
Corium, LLC	1	$21
Lundbeck LLC	1	$16
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,017 in reported general payments places this provider in the 95th percentile of 36 child & adolescent psychiatry providers in Oregon.

See all child & adolescent psychiatry providers in Oregon →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	28	$54,947
Lisdexamfetamine Dimesylate	14	$3,634
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	47	$2,833
Duloxetine Hcl	40	$2,036
Bupropion XlBupropion Hcl	68	$1,929
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	32	$1,600
Oxcarbazepine	17	$1,320
Divalproex Sodium ErDivalproex Sodium	19	$798
Alprazolam	46	$651
Lamotrigine	40	$645
Gabapentin	33	$623
Aripiprazole	18	$552
Lorazepam	47	$477
Quetiapine Fumarate ErQuetiapine Fumarate	12	$369
Escitalopram Oxalate	30	$363

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$538	$54,94728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 36 child & adolescent psychiatry providers in Oregon.

Other child & adolescent psychiatry in Hood River

Stewart NewmanHillsboro$2K
David Conant-NorvilleHillsboro$1K
Lorraine DaviesGrants Pass$1K
Eric LeongCorvallis$982
Jin CaiOregon City$675
Kathryn FlegelPortland$625
Linda YoungMedford$408
Kirk WolfePortland$324
David WhiteLake Oswego$136
Erin SuttonBend$131

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →